Latest Development Activity News

Advent Energy, with BPH Energy as a significant stakeholder, has launched a judicial review against the Federal Government’s refusal to extend the PEP-11 offshore petroleum permit, seeking to overturn the decision and force reconsideration.

Tamboran Resources Corporation posted a $20 million net loss for the half year ending December 31, 2024, reflecting intensified exploration and development activities in the Beetaloo Basin amid no revenue generation. The company’s cash reserves declined to $59.4 million, underscoring the pressing need for additional capital to fund ongoing projects.

Tamboran Resources reports significant progress in its Beetaloo Basin development, including record-setting drilling, strong cash reserves, and strategic partnerships, positioning itself for first gas in 1H 2026 and exploring new growth avenues.

Ora Banda Mining's latest drilling at Riverina confirms deep, high-grade gold mineralisation, extending mine life and prompting a $45 million investment to accelerate exploration and infrastructure expansion.

Adelong Gold Limited has secured an additional $400,000 through a placement, increasing total funds raised to $1.573 million. This capital injection aims to fast-track exploration and development at its flagship gold project and lithium assets in Brazil.

Brightstar Resources has entered a strategic earn-in agreement with Cazaly Resources, allowing Cazaly to earn up to 80% of the Goongarrie Gold Project by funding $3 million in exploration. This move streamlines Brightstar’s portfolio, enabling a sharper focus on advancing key development projects.

Resouro Strategic Metals Inc. posted a $5.28 million net loss for the nine months ended December 31, 2024, reflecting increased exploration and administrative expenses as it advances its Tiros Titanium and Rare Earth Elements Project. The company bolstered its balance sheet with a successful ASX dual listing and private placements but faces ongoing challenges to sustain operations.

Lodestar Minerals has increased its capital raising placement by $22,500, bringing the total to $542,500, subject to shareholder approval at an upcoming meeting.

Neuren Pharmaceuticals has received a significant cash inflow of approximately US$50 million following the sale of a Priority Review Voucher linked to its Rett syndrome treatment. This milestone underscores the growing value of Neuren’s neurological drug portfolio and its partnership with Acadia Pharmaceuticals.

Adelong Gold Limited has raised $1.173 million through a placement to fund exploration and development at its NSW gold project and lithium ventures in Brazil. The capital raise, including free attaching options, signals investor confidence as the company advances towards production.

Invex Therapeutics reports a significant reduction in net loss for H1 FY2025 alongside promising pre-clinical data for Exenatide in Alzheimer’s Disease models.

Carnaby Resources has completed the settlement of Tranche 2 of its recent share placement, issuing 13.5 million new shares to raise approximately $4.2 million, including participation from its board members.